Pacific Biosciences of California, Inc. Inventory, Work in Process, Net of Reserves
Pacific Biosciences of California, Inc. (PACB) had Inventory, Work in Process, Net of Reserves of $18.29 million as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Notes › Inventory › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryWorkInProcessNetOfReserves · last filed 2024-11-12
- 2024-09-30: Inventory, Work in Process, Net of Reserves $18.29M.
- 2024-06-30: Inventory, Work in Process, Net of Reserves $21.70M.
- 2024-03-31: Inventory, Work in Process, Net of Reserves $26.30M.
- 2023-12-31: Inventory, Work in Process, Net of Reserves $23.44M.
| Period end | Inventory, Work in Process, Net of Reserves |
|---|---|
| 2024-09-30 | $18.29M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $21.70M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $26.30M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $23.44M 10-Q · filed 2024-11-12 |
| 2023-09-30 | $27.88M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $22.60M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $21.70M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $14.06M 10-K · filed 2024-02-28 |
| 2022-09-30 | $13.46M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $12.81M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $9.20M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $8.61M 10-K · filed 2023-02-28 |
| 2021-09-30 | $8.76M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $9.05M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $6.86M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $6.65M 10-K · filed 2022-02-28 |
| 2020-09-30 | $5.44M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $5.79M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $5.82M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $4.59M 10-K · filed 2021-02-26 |
| 2019-09-30 | $3.87M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $4.90M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $9.10M 10-Q · filed 2019-05-03 |
| 2018-12-31 | $7.34M 10-K · filed 2020-02-28 |
| 2018-09-30 | $7.37M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $10.36M 10-Q · filed 2018-08-03 |
| 2018-03-31 | $11.06M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $9.99M 10-K · filed 2019-02-26 |
| 2017-09-30 | $7.04M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $6.70M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $5.97M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $7.29M 10-K · filed 2018-02-26 |
| 2016-09-30 | $8.34M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $5.08M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $4.80M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $3.58M 10-K · filed 2017-03-06 |
| 2015-09-30 | $4.48M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $7.00M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $9.75M 10-Q · filed 2015-05-05 |
| 2014-12-31 | $6.12M 10-K · filed 2016-03-11 |
| 2014-09-30 | $5.42M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $4.25M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $4.00M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $4.01M 10-K · filed 2015-03-12 |
| 2013-09-30 | $4.22M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $5.18M 10-Q · filed 2013-08-09 |
| 2012-12-31 | $3.49M 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |